June 28 (Reuters) - Asset manager Oaktree Capital
Management L.P. on Wednesday named insiders Robert O Leary and
Armen Panossian as co-CEOs to replace Jay Wintrob, who is
resigning in the first quarter of 2024. .
Oaktree Capital Management closed its Life Sciences Lending Fund and its related vehicles (“the Fund”), with total capital commitments in excess of $2.3 billion. The Fund, which is Oaktree’s first dedicated life sciences fund, was oversubscribed and builds on our track record of successfully investing in this specialized field for over a decade.
Operator: Welcome and thank you for joining Oaktree Specialty Lending Corporation Second Fiscal Quarter 2023 Conference Call. Today s conference call is being recorded.